Management Algorithms for Relapsed/Refractory AL Amyloidosis

Authored by Rajshekhar Chakraborty, published on 2026-04-16 07:43:35.0

  1. Relapsed/Refractory AL Amyloidosis after Frontline Dara-CyBorD
    • Indications for switching therapy
      • t(11;14)-positive
        • Treatment options (t(11;14)-positive)
      • t(11;14)-negative or unknown
        • Treatment options (t(11;14)-negative or unknown)
  2. * Consider fixed-duration treatment for 6 months
tosprivacy